Research to improve the lives of drug users and investigate high rates of falls in Aboriginal and Torres Strait Islander people are the biggest UNSW winners in the final round of 2017 NHMRC funding.
Reviews of the global prevalence of injecting drug use and of interventions to prevent the spread of blood-borne viruses among people who inject drugs paint a worrying picture.
As new treatments for hepatitis C reshape the landscape, new data from UNSW underscore the need to address issues including discrimination, stigma and engaging marginalised communities.
Tens of thousands of Australians have been cured of Hepatitis C since March 2016, writes Greg Dore.
Research from The Kirby Institute released for World Hepatitis Day shows Australia could be one of the first countries in the world to eliminate hepatitis C.
The newer drugs for hepatitis C might mean fewer people are diagnosed with liver cancer, write Maryam Alavi and Greg Dore.
More Australians have been treated for hepatitis C in the past 12 months than the last decade combined, following the listing of a new generation therapy on the Pharmaceutical Benefits Scheme.
A UNSW research trial to examine if e-cigarettes can help smokers quit and a world-first treatment for teenagers with PTSD and substance abuse are among projects to receive major backing in the latest NHMRC funding round.
New hepatitis C treatments are expensive but Greg Dore and Marianne Martinello argue that facilitating global access to safe, direct-acting antivirals will herald a revolution.
Australian researchers are leading the world in the battle to eliminate hepatitis C.